The street value of Soma, a brand name for carisoprodol, is not readily available information. Carisoprodol is a prescription muscle relaxant and its illicit sale or possession is illegal [1]. Information regarding the street value of controlled substances is typically not publicly documented and can vary significantly based on location, purity, and availability.
What is carisoprodol and what is it prescribed for?
Carisoprodol is a medication used to relieve discomfort associated with acute, painful musculoskeletal conditions [2]. It works by affecting the communication between nerves and muscles. It is typically prescribed for short-term use in conjunction with rest and physical therapy.
Is carisoprodol a controlled substance?
Carisoprodol is classified as a Schedule IV controlled substance by the U.S. Drug Enforcement Administration (DEA) [3]. This classification indicates that it has a low potential for abuse relative to substances in Schedule III and a currently accepted medical use in treatment in the United States. Due to its potential for abuse and dependence, its prescription and dispensing are regulated [4].
What are the risks associated with carisoprodol use?
Carisoprodol can cause side effects, including drowsiness, dizziness, and headache. More serious risks include dependence, abuse, and withdrawal symptoms upon abrupt cessation [5]. In some individuals, carisoprodol is metabolized into meprobamate, which has a higher potential for abuse and dependence [6]. Overdose can lead to severe central nervous system depression [5].
Where can I find legal information about carisoprodol?
For accurate and legal information regarding carisoprodol, including its prescription, use, and regulation, consult official sources such as the U.S. Food and Drug Administration (FDA) or the U.S. Drug Enforcement Administration (DEA) [1, 3, 4].
Sources:
1. U.S. Food and Drug Administration. (n.d.). Drug Approval Process. Retrieved from https://www.fda.gov/
2. National Institutes of Health. (n.d.). Carisoprodol. MedlinePlus. Retrieved from https://medlineplus.gov/
3. U.S. Drug Enforcement Administration. (n.d.). Controlled Substances Act. Retrieved from https://www.dea.gov/
4. U.S. Drug Enforcement Administration. (n.d.). Drug Scheduling. Retrieved from https://www.dea.gov/drug-scheduling
5. U.S. National Library of Medicine. (n.d.). Carisoprodol side effects. MedlinePlus. Retrieved from https://medlineplus.gov/
6. U.S. Food and Drug Administration. (2010, October 19). FDA Drug Safety Communication: FDA requests label changes to warn about carisoprodol (Soma) dependence, abuse, and misuse. Retrieved from https://www.fda.gov/